About the LOLIPOP trial

The LOLIPOP Trial is a large, international, multicentre, double blind, randomised controlled trial that will recruit 4,300 women undergoing breast cancer surgery.

The trial will investigate whether chronic pain can be prevented by giving a local anaesthetic, lidocaine, intravenously during and up to 24 hours after breast cancer surgery.

The study team is led by Professor Tomás Corcoran and the trial is being conducted by the Australian and New Zealand College of Anaesthetists (ANZCA) Clinical Trials Network (CTN), Monash University and Royal Perth Hospital.

This research has been initiated by the study doctor, Professor Tomás Corcoran and has received $4.3 million in funding from the NHMRC Medical Research Future Fund (MRFF) in Australia. This research is being conducted by the Australian and New Zealand College of Anaesthetists (ANZCA) Clinical Trials Network (CTN), Monash University and Royal Perth Hospital. Monash University is the sponsor of this trial, with overall responsibility for it.